Ex-FDA chief Hahn joins Moderna backer To view this email as a web page,
click here AstraZeneca's COVID-19 antibody combination fails post-exposure prevention trial Two shots of Pfizer, AstraZeneca COVID-19 vaccines effective against Delta variant: study He authorized Moderna's vaccine 6 months ago. Now, ex-FDA chief Hahn joins biotech's backer More physicians have become millionaires since before the pandemic, survey finds COVID-19 tracker: Novavax shot remains effective alongside flu jab; NIH study finds evidence of late 2019 infections UPDATED Coronavirus tracker: Assisted living residents' all-cause mortality increased 17% as COVID-19 spread through US Featured Story | By Nick Paul Taylor AstraZeneca’s anti-SARS-CoV-2 antibody combination has failed a phase 3 clinical trial designed to assess its ability to prevent symptomatic COVID-19 in people recently exposed to the pandemic coronavirus. However, while the study missed its primary endpoint, a subgroup analysis of people who were PCR-negative at baseline offered encouragement to AstraZeneca. read more |
| |
|---|
|
| | Who’s Watching Your Clinical Trial Supply Chain? With the ever-increasing costs of clinical trials and the advantages of being first-to-market, it’s time to take a closer look at your supply chain to ensure it delivers with speed, efficiency, and quality — all within your budget. Learn about key strategies for mitigating risk in clinical trials. Learn more. |
Top Stories By Kevin Dunleavy In a real-world study in the U.K., two shots of the Pfizer or AstraZeneca COVID-19 vaccine were effective in preventing hospitalizations caused by the Delta variant, which scientists first detected in India. read more By Kyle LaHucik Ex-FDA Commissioner Stephen Hahn, M.D., is joining Moderna incubator Flagship Pioneering six months after granting the company an emergency use authorization for its COVID-19 vaccine. read more By Dave Muoio A poll of nearly 18,000 U.S. physicians suggests home ownership and other pre-pandemic investments helped many doctors break seven figures during a volatile year. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner Novavax said its COVID-19 shot remained highly effective when administered alongside an already-approved influenza vaccine. A new government study found evidence of COVID-19 infections in the U.S. as early as December 2019. And more headlines. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more |
|
